PlushCare takes a different approach than most GLP-1 telehealth platforms
Injectable GLP-1 formulations (subcutaneous semaglutide, tirzepatide) do not have this timing issue since they bypass the gastrointestinal tract for absorption
Contact your physician or go to the ER if you experience: Vomiting lasting more than 24 hours, preventing you from keeping fluids down Dehydration signs such as dizziness, dry mouth, rapid heartbeat, or dark urine Sharp, constant upper abdominal pain, especially if it radiates to your back Fever, jaundice (yellowing of the skin or eyes), or bloody vomit/stool Confusion, extreme fatigue, or fainting Most individuals can manage GLP-1 side effects at home, but knowing when to seek further care is essential
All of the five therapeutic GLP-1RAs, currently approved for therapy of type 2 diabetes, are peptide molecules, which are administered in subcutaneous injections
That means (in addition to sleep, movement and nutrition tools) offering the option of oral medications, compounded GLP-1s, or branded GLP-1 medications (as supply becomes more readily available), so that customers can truly personalize their experience
Understand the realistic timeline for results